AstraZeneca and Absci partnership paves the way for AI-generated cancer antibodies, potentially eliminating the need for chemotherapy

AstraZeneca and Absci have signed a deal worth $247 million to collaborate on developing cancer antibodies using generative AI, reports Reuters. AstraZeneca aims to replace chemotherapy and sees this partnership as a significant step towards achieving that goal. They plan to use Absci’s AI technology for large-scale protein analysis to search for a workable cancer […]

Continue Reading

“Doc.com: Revolutionizing Medicine Access with an Innovative Healthcare Solution”

Doc.com, founded by Charles Nader, is a digital healthcare service that aims to revolutionize the accessibility of healthcare. The CEO, Charles Nader, envisions a future where healthcare is a right for everyone, rather than a privilege for the few. The app offers technological benefits such as precise diagnosis, blockchain rewards, and statistical public health analytics. […]

Continue Reading

Price of Paxlovid, a medication for COVID-19, predicted to increase in 2024

COVID-19 Medication Paxlovid’s Price Expected to Rise in 2024 In a recent development, Paxlovid, a crucial medication for COVID-19, is projected to see a significant increase in price as the US transitions out of the pandemic’s emergency phase. This has raised concerns about accessibility, with healthcare professionals worried about the impact on patients. Similar to […]

Continue Reading